SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-043990
Filing Date
2013-08-08
Accepted
2013-08-08 16:31:10
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v351133_10q.htm 10-Q 329558
2 EX-31.1 v351133_ex31-1.htm EX-31.1 9630
3 EX-31.2 v351133_ex31-2.htm EX-31.2 9535
4 EX-32.1 v351133_ex32-1.htm EX-32.1 4107
5 EX-32.2 v351133_ex32-2.htm EX-32.2 4365
  Complete submission text file 0001144204-13-043990.txt   2555700

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20130630.xml EX-101.INS 184405
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20130630.xsd EX-101.SCH 19582
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20130630_cal.xml EX-101.CAL 31985
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20130630_def.xml EX-101.DEF 42482
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20130630_lab.xml EX-101.LAB 246909
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20130630_pre.xml EX-101.PRE 106760
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 131022622
SIC: 2836 Biological Products, (No Diagnostic Substances)